Swiss Flag

Oncology

Eisai is dedicated to discovering, developing and producing innovative oncology therapies that can improve and prolong the lives of cancer patients around the world.

Breast cancer is the most common form of cancer in women. More than one million women a year are diagnosed with breast cancer worldwide 1,2.

Survival rates for early diagnosed breast cancer have improved dramatically in recent years, however most women diagnosed with metastatic breast cancer still only live for less than two years after diagnosis3.

References
Coughlin, S. Breast cancer as a global health concern. Cancer Epidemiology, October 2009; 33: 315-18. www.hsph.harvard.edu/breastandhealth/files/ekaterina_bashta.pdf. [Accessed March 2013] Fernandez Y, Cueva J, Palomo AG, et al. Novel therapeutic approaches to the treatment of metastatic breast cancer. Cancer Treat Rev.2010:36(1):33-42

Working for Eisai

Eisai regularly have opportunities in a number of functional disciplines across our EMEA and Swiss operations. View our current vacancies

Job code Corporate-EU0005 / Date of preparation September 2014